BioCentury | Jun 17, 2020
Emerging Company Profile
Lightspeed, Klausner back Stanford cell therapy spinout Orca in new $192M round
...therapies that use controlled formulations designed to reduce toxicity compared with traditional bone marrow transplants. Orca Biosystems Inc....
...AG (NYSE:NVS; SIX:NOVN); and Ted Love, CEO of Global Blood Therapeutics Inc. (NASDAQ:GBT). COMPANY PROFILE Orca Biosystems Inc....
...AG (NYSE:NVS; SIX:NOVN); and Ted Love, CEO of Global Blood Therapeutics Inc. (NASDAQ:GBT). COMPANY PROFILE Orca Biosystems Inc....
